MI4A Market Studies
Cross-antigen market studies
MI4A cross-antigen market studies identify specific areas critical to vaccine access within the broader market landscape—often spanning multiple vaccines—where relevant and topical developments are taking place. These studies provide in-depth analytical insights and frequently inform or articulate the organization’s position on the issue under review.
Global market landscape of vaccine manufacturing and procurement
This landscape analysis aims to present a current picture of the global vaccine ecosystem from the purchaser (country) and supplier (manufacturer) perspectives...
Vaccine-specific market studies
MI4A produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies identify areas of risk for sustainable access to vaccine supply and define mitigating actions. Market studies are available for:
/immunization-vaccines-and-biologicals-(ivb)/immunization-analysis-insights-(iai)/who-global-market-study-on-rsv-immunization-products_november-2024-89.tmb-144v.jpg?sfvrsn=d31cd58a_1)
WHO Global Market Study on RSV Immunization Products
MI4A produces antigen-specific market studies, analyzing global demand and supply dynamics for products targeting a specific antigen.The Global Market...
WHO Hepatitis A Vaccine Global Market Study, February 2023
MI4A produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies identify areas of risk...
WHO HPV Vaccine Global Market Study, April 2022
MI4A produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies identify areas of risk...
WHO Seasonal Influenza Vaccine Global Market Study, January 2024
MI4A produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies identify areas of risk...
Impact of SARS-CoV-2 pandemic on supply demand of non-COVID-19 vaccines
Mitigating impact of SARS-CoV-2 pandemic on available supply for commercialization and programmatic doses...
In the context of the COVID-19 pandemic and the unprecedented efforts to develop, manufacture, and deliver large quantities of COVID-19 vaccines, the global...
Mitigating the impact of the COVID-19 pandemic on available supply for commercialization and programmatic...
In the context of the COVID-19 pandemic and the unprecedented efforts to develop, manufacture, and deliver large quantities of COVID-19 vaccines, the global...
For more information, please contact [email protected]